The FDA has granted accelerated approval to Bristol Myers Squibb’s Zenbexus, the first FDA-approved cereblon E3 ligase modulator, or CELMoD, a new class of treatment for multiple myeloma. Zenbexus (iberdomide), in combination with daratumumab and hyaluronidase-fihj and dexamethasone, was approved…

Chicago-based Lurie Children’s has opened its first outpatient specialty pharmacy at its Outpatient and Infusion Center in Schaumburg, Ill. The pharmacy provides filling prescriptions, home delivery and a selection of over-the-counter medications, according to an Aug. 13 news release. Specialty…

Norton Healthcare’s $29.8 million retail pharmacy and central-fill operation in Louisville, Ky., is now operational. The health system celebrated the pharmacy’s grand opening Aug. 13, though the facility opened to patients July 20.  The pharmacy, staffed by 30 employees, serves…

About 1 in 5 second-level appeals of denied anticancer medications in Medicare Part D were overturned, according to a study published July 23 in JAMA Network Open. Researchers analyzed 4,952 second-level appeals from 2020 to 2024. Here are four things…

VYKAT XR (diazoxide choline), the first FDA-approved medication specifically indicated for hyperphagia in patients ages 4 and older with Prader-Willi syndrome, is facing increased safety scrutiny following reports of seven deaths and more than 100 serious adverse events. The reported…

Prescription drug prices fell 3.1% over the 12 months ending in July — the steepest annual decline in more than six decades, according to the Bureau of Labor Statistics’ Consumer Price Index report released Aug. 12. The prescription drug index…

Fifty-six percent of employer clients of “Big Three” pharmacy benefit managers — CVS Caremark, Cigna’s Express Scripts and UnitedHealth Group’s Optum Rx — are thinking about switching in the next one to three years. The 2026 “Pulse of the Purchaser”…

When Valhalla, N.Y.-based Westchester Medical Center Health Network recruited its chief pharmacy officer, Urshila Shah, PharmD, CEO David Lubarsky, MD, gave her an ambitious task: launch an in-house specialty pharmacy within six months. The health system met that goal. The…

AstraZeneca’s board scrapped merger talks with Bristol Myers Squibb on Aug. 3, days after reports emerged that the companies were discussing a roughly $400 billion tie-up, according to an Aug. 11 report from the Financial Times. The two companies had…

The FDA has rejected a radiopharmaceutical therapy from ITM Isotope Technologies Munich that was positioned to compete with Novartis’ leading treatments in the space. The agency issued a complete response letter for ITM-11, also known as 177Lu-edotreotide, saying it cannot…